VITASPRING BIOMEDICAL CO. LTD.: auditor change — Auditor TAAD resigns; four directors/officers exit; Dr. Lai appointed CEO/CFO/Chair

VITASPRING BIOMEDICAL CO. LTD.

TAAD LLP resigned as independent auditor effective Aug 5, 2025; no disagreements or reportable events.
Effective Aug 7, 2025, Lin Jer-Li, Chen YenXun, Chu Pao-Chi, and Kao Cheng-Hsiang resigned from all positions.
Dr. Ssu-Chuan Lai appointed Chairperson, CEO, and CFO effective Aug 7, 2025.
Dr. Lai previously Vice General Manager at Biospring Medical, with cell manufacturing and regulatory expertise.
Resignations were not due to any disagreements with the company's operations, policies, or practices.

item 4.01 item 5.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

TAAD LLP resigned as auditor of VITASPRING BIOMEDICAL CO. LTD..

Action: resignation
Auditor: TAAD LLP

Exact text from the filing

On August 5, 2025, TAAD LLP (“TAAD”) resigned as our independent registered public accounting firm, effective immediately.

View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR

accession 0001683168-25-005896

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.